ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Multicultural Healthy Diet to Reduce Cognitive Decline

ClinicalTrials.gov ID: NCT03240406

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03240406. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a pilot randomized controlled clinical trial is designed to investigate whether the Multicultural Healthy Diet (MHD), an anti-Inflammatory diet tailored to a multi-cultural population, can improve cognitive functioning in a middle aged (40-65 yr) urban population in Bronx, New York compared to a usual diet.

Study identification

NCT ID: NCT03240406
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Albert Einstein College of Medicine; Other
Enrollment: 393 participants

Conditions and interventions

Conditions

Interventions

Multicultural Healthy Diet Other
Usual Diet plus Self-Care Other

Other

Eligibility (public fields only)

Age range: 40 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 2, 2018 (Actual)
Primary completion: Jul 3, 2023 (Actual)
Completion: Aug 30, 2023 (Actual)
Last update posted: Dec 12, 2024

2018 – 2023

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Albert Einstein College of Medicine	The Bronx	New York	10461	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03240406, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 12, 2024 · Synced Nov 15, 2026